CMS needs to improve oversight of Medicare Part B drug payment calculations, OIG report finds
(By Jakob Emerson for Becker’s Hospital Review) CMS needs better strategies to ensure proper oversight of Medicare Part B drug
Read moreDHS -OIG
Cigna received $5.9M in Medicare Advantage overpayments, OIG says
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage plan Cigna HealthSpring of Tennessee received $5.9 million in overpayments from
Read moreHow Medicare Advantage plans dodged auditors and overcharged taxpayers by millions
(By Fred Schulte and Holly K. Hacker for NPR) In April 2016, government auditors asked a Blue Cross Medicare Advantage
Read moreKHN Investigation: The System Feds Rely On to Stop Repeat Health Fraud Is Broken
(By Sarah Jane Tribble and Lauren Weber for Kaiser Health News) The federal system meant to stop health care business
Read more9 Medicare Advantage plans audited for upcoding by OIG in the last 6 months
(By Rylee Wilson for Becker’s Hospital Review) The HHS’ Inspector General’s Office released audits of nine Medicare Advantage plans over
Read moreCMS changes successfully reduced outpatient overpayments, OIG audit finds
(By Rylee Wilson for Becker’s Hospital Review) Oversight changes CMS made in its system to identify patients in inpatient services
Read moreOIG: Better oversight needed for Medicaid beneficiaries enrolled in two states
(By Rylee Wilson for Becker’s Hospital Review) The HHS Office of Inspector General found states frequently pay capitation benefits for
Read moreAdverse Events in Hospitals: A Quarter of Medicare Patients Experienced Harm in October 2018
(Source – oig.hhs.gov) In 2010, OIG reported the first national incidence rate of patient harm events in hospitals-27 percent of
Read moreMedicare Advantage Organization denials of prior authorization requests raise concerns
(By Andrew Cass for Becker’s Hospital Review) A report from the HHS Office of the Inspector General released April 27
Read more6 drugmakers referred to HHS inspector general for denying 340B discounts
(By Maia Anderson for Becker’s Hospital Review) The HHS Health Resources & Services Administration sent letters to six drugmakers Sept.
Read more